Secure data leadership Medexprim specializes in secure imaging and regulatory-grade real-world data extraction, offering a compelling value proposition for pharma, AI, and device companies seeking compliant access to multicentric datasets for oncology, neurology, cardiology, and rare diseases.

European collaboration As a European leader connected to BC Platforms and links with European academic hospitals, Medexprim presents a networked opportunity for regional partnerships, co-development projects, and access to diverse clinical data sources.

Multimodal capabilities Their focus on multimodal real-world datasets enables cross-domain use cases, such as imaging combined with clinical and omics data, which can attract AI model training, real-world evidence studies, and precision medicine initiatives.

Expansion signals Recent partnerships and acquisitions, including BC Platforms’ acquisition of Medexprim, indicate growth momentum and potential for scaled collaboration, integration into broader platforms, and expanded go-to-market opportunities.

Growth potential With a small team and revenue in the low single-digit millions, there is opportunity to upsell data processing services, AI-powered analytics, and regulatory-grade data enrichment to larger pharma/biotech clients seeking efficient RWD workflows.